REDOXIS Trademark

Trademark Overview


On Friday, February 14, 2025, a trademark application was filed for REDOXIS with the United States Patent and Trademark Office. The USPTO has given the REDOXIS trademark a serial number of 79420502. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Saturday, September 20, 2025. This trademark is owned by Redoxis AB. The REDOXIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research; biological research, clinical research in the fields of immunology, autoimmunity, diagnostics and treatment of inflammation and neurodegenerative diseases, and medical research; biological research services; pharmaceutical research services; research on the subject of pharmaceuticals; scientific research in the field of pharmacy; advisory services relating to scientific research; pharmaceutical research and development services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; conducting early evaluations in the field of new pharmaceuticals; medical research laboratory services; laboratory research services relating to pharmaceuticals
redoxis

General Information


Serial Number79420502
Word MarkREDOXIS
Filing DateFriday, February 14, 2025
Status680 - APPROVED FOR PUBLICATION
Status DateSaturday, September 20, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the literal element "REDOXIS" in lowercase letters. To the left of "REDOXIS" is a red circular icon containing a white abstract figure resembling a person with raised arms. The "X" in "REDOXIS" is also represented in red whilst the remaining letters are in black.
Indication of Colors claimedThe color(s) red, black, and white is/are claimed as a feature of the mark.
Goods and ServicesMedical research; biological research, clinical research in the fields of immunology, autoimmunity, diagnostics and treatment of inflammation and neurodegenerative diseases, and medical research; biological research services; pharmaceutical research services; research on the subject of pharmaceuticals; scientific research in the field of pharmacy; advisory services relating to scientific research; pharmaceutical research and development services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; conducting early evaluations in the field of new pharmaceuticals; medical research laboratory services; laboratory research services relating to pharmaceuticals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 3, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRedoxis AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSE

Trademark Events


Event DateEvent Description
Thursday, April 3, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 4, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 23, 2025NON-FINAL ACTION WRITTEN
Friday, April 4, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, July 22, 2025ASSIGNED TO EXAMINER
Wednesday, August 27, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 19, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, September 20, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 19, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 24, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 27, 2025REFUSAL PROCESSED BY MPU
Friday, September 12, 2025REFUSAL PROCESSED BY IB
Friday, September 19, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED